EyePoint Pharmaceuticals, Inc. (EYPT) reported that Nancy Lurker, a direct holder, completed a purchase transaction of 3,173 shares of common stock on August 16, 2024. The shares were acquired at a price of $7.88 per share, resulting in a total investment of $25,003.64. Following this transaction, Lurker's direct holdings in the company increased to 97,635 shares. Additionally, it was disclosed that there are 126,889 shares held indirectly by a family trust associated with Lurker.

EyePoint Pharmaceuticals, Inc. (EYPT) reported that Nancy Lurker, a direct holder, completed a purchase transaction of 3,173 shares of common stock on August 16, 2024. The shares were acquired at a price of $7.88 per share, resulting in a total investment of $25,003.64. Following this transaction, Lurker's direct holdings in the company increased to 97,635 shares. Additionally, it was disclosed that there are 126,889 shares held indirectly by a family trust associated with Lurker.